Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Nadeau

Showing results (311-320 of 387) with videos related to

Pageof 39
Sort By:
Allergy|June 3, 2026
Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental ExposuresThinh H Nguyen, Cezmi Akdis, Andrea Baccarelli, et al.
Allergy|June 11, 2025
The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and AsthmaIoana Agache, Josefina Salazar, Yesenia Rodriguez-Tanta, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disordersSayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
Frontiers in Allergy|January 5, 2026
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methodsA J Long, S Sindher, K Martinez, et al.
The Journal of Climate Change and Health|February 6, 2026
Climate change and allergic diseases: A scoping reviewIoana Agache, Cezmi Akdis, Mubeccel Akdis, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
Frontiers in Medicine|September 20, 2023
Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort studyIsaac Núñez, Joshua Gillard, Sergio Fragoso-Saavedra, et al.
Nature|January 22, 2025
RELMβ sets the threshold for microbiome-dependent oral toleranceEmmanuel Stephen-Victor, Gavin A Kuziel, Monica Martinez-Blanco, et al.
Immunity|March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infectionFei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Pageof 39

Showing results (311-320 of 387) with videos related to

Sort By:
Pageof 39
Allergy|June 3, 2026
Leveraging Artificial Intelligence in Allergy, Asthma, and Immunology With Environmental ExposuresThinh H Nguyen, Cezmi Akdis, Andrea Baccarelli, et al.
Allergy|June 11, 2025
The Impact of Rhinovirus, Syncytial Respiratory Virus and Helminth Infection on the Risk of New-Onset Asthma and Other Allergic Conditions-A Systematic Review for the EAACI Guidelines on Environmental Science for Allergic Diseases and AsthmaIoana Agache, Josefina Salazar, Yesenia Rodriguez-Tanta, et al.
Allergy|January 7, 2017
Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysisU Nurmatov, S Dhami, S Arasi, et al.
The Journal of Allergy and Clinical Immunology|March 5, 2023
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disordersSayantani B Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
Frontiers in Allergy|January 5, 2026
A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methodsA J Long, S Sindher, K Martinez, et al.
The Journal of Climate Change and Health|February 6, 2026
Climate change and allergic diseases: A scoping reviewIoana Agache, Cezmi Akdis, Mubeccel Akdis, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
Frontiers in Medicine|September 20, 2023
Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort studyIsaac Núñez, Joshua Gillard, Sergio Fragoso-Saavedra, et al.
Nature|January 22, 2025
RELMβ sets the threshold for microbiome-dependent oral toleranceEmmanuel Stephen-Victor, Gavin A Kuziel, Monica Martinez-Blanco, et al.
Immunity|March 30, 2023
Spheromers reveal robust T cell responses to the Pfizer/BioNTech vaccine and attenuated peripheral CD8<sup>+</sup> T cell responses post SARS-CoV-2 infectionFei Gao, Vamsee Mallajosyula, Prabhu S Arunachalam, et al.
Pageof 39